Intravenous immunoglobulin for severe sepsis and septic shock: clinical effectiveness, cost-effectiveness and value of a further randomised controlled trial
Crossref DOI link: https://doi.org/10.1186/s13054-014-0649-z
Published Online: 2014-12-01
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Soares, Marta O
Welton, Nicky J
Harrison, David A
Peura, Piia
Shankar-Hari, Manu
Harvey, Sheila E
Madan, Jason
Ades, Anthony E
Rowan, Kathryn M
Palmer, Stephen J
License valid from 2014-12-01